Loading...
Engineering immunomodulatory biomaterials for type 1 diabetes
A cure for type 1 diabetes (T1D) would help millions of people worldwide, but remains elusive thus far. Tolerogenic vaccines and beta cell replacement therapy are complementary therapies that seek to address aberrant T1D autoimmune attack and subsequent beta cell loss. However, both approaches requi...
Saved in:
| Published in: | Nat Rev Mater |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2019
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7332200/ https://ncbi.nlm.nih.gov/pubmed/32617176 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41578-019-0112-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|